Ron discusses the unique properties of modified mRNA vaccines, highlighting how they differ from traditional vaccines by turning cells into manufacturing sites for viral proteins. He raises concerns about the body's inflammatory response to foreign proteins and questions the necessity of creating a toxic platform for vaccine development. The conversation also touches on the effectiveness of natural immunity in combating infections.
